YAP/TAZ amplification and nuclear localisation has been noted in various cancers such as hepatocellular carcinoma21,22, colorectal cancer23,24, lung cancer25 and ovarian cancer26 and is linked to a worse prognosis, tumour de-differentiation and increased tumour malignancy. This evidence concerns the gene WWTR1 and neoplasm.